Cargando…
Middle-age Asian male with cerebral venous thrombosis after COVID-19 AstraZeneca vaccination
Vaccine-associated cerebral venous thrombosis has become an issue following the extensive vaccination program of the Coronavirus Disease of 2019 (COVID-19) Vaccine AstraZeneca (ChAdOx1 vaccine). The importance of early diagnosis should be emphasized due to the high mortality rate without appropriate...
Autores principales: | Guan, Che-Yu, Tsai, Shi-Hung, Fan, Ju-Sing, Lin, Yu-Kai, Kao, Chih-Chun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265178/ https://www.ncbi.nlm.nih.gov/pubmed/34274191 http://dx.doi.org/10.1016/j.ajem.2021.07.011 |
Ejemplares similares
-
AstraZeneca COVID-19 vaccine: thrombosis with thrombocytopenia
Publicado: (2021) -
AstraZeneca COVID-19 vaccine-related thrombocytopenia and thrombosis
Publicado: (2021) -
Thrombocytopenia and Intracranial Venous Sinus Thrombosis after “COVID-19 Vaccine AstraZeneca” Exposure
por: Wolf, Marc E., et al.
Publicado: (2021) -
Cerebral venous sinus thrombosis following intracerebral hemorrhage after COVID‐19 AstraZeneca vaccination: A case report
por: Haj Mohamad Ebrahim Ketabforoush, Arsh, et al.
Publicado: (2022) -
Anaphylaxis in Australia with AstraZeneca's COVID-19 vaccine
Publicado: (2021)